{"id":"nct:NCT02000089","kind":"trial","title":"The Cancer of the Pancreas Screening-5 CAPS5)Study","authors":["Johns Hopkins University"],"author_count":1,"year":2013,"published":"2013-12-03","venue":"ClinicalTrials.gov","cited_by":null,"doi":null,"arxiv_id":null,"nct_id":"NCT02000089","source_url":"https://clinicaltrials.gov/study/NCT02000089","archive_url":"https://space-kitty.com/papers/nct:NCT02000089","updated":"2026-10-22","pmid":null,"pmcid":null,"openalex_id":null,"pdf_url":null,"abstract":"Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.","abstract_license":"ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters","license":"ClinicalTrials.gov terms (attribution, processing date, modifications noted)","is_open_access":true,"peer_reviewed":null,"categories":["Pancreas Cancer","Peutz-Jeghers Syndrome (PJS)","Gene Mutation","Germline Mutation Carrier","Lynch Syndrome"],"details":{"acronym":"CAPS5","status":"RECRUITING","phase":"PHASE3","study_type":"INTERVENTIONAL","enrollment":9000,"sponsor":"Johns Hopkins University","conditions":["Pancreas Cancer","Peutz-Jeghers Syndrome (PJS)","Gene Mutation","Germline Mutation Carrier","Lynch Syndrome"],"interventions":["DRUG: Secretin","DIAGNOSTIC_TEST: MRI","OTHER: Tumor marker gene test with CA19-9"],"start_date":"2014-01-06","start_date_type":"ACTUAL","primary_completion_date":"2028-12-01","has_results":false,"data_source":"ClinicalTrials.gov","data_processed":"2026-10-29T09:00:05","modifications":"selected fields only; whitespace normalized; brief summary truncated to 2,000 characters"},"provenance":"clinicaltrials","attribution":"Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.","topics":[{"slug":"gene-cell-therapy","name":"Gene & Cell Therapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}